Related Experiment Videos
A method for provoking EEG abnormalities by administration of nialamide
Folia Psychiatrica Et Neurologica Japonica
|January 1, 1977
Summary
Nialamide, a monoamine oxidase inhibitor, provokes centrencephalic EEG abnormalities and symptoms in patients with existing brainstem dysfunction. This EEG provocation method effectively identified abnormalities and worsened clinical symptoms in over 70% of patients.
Area of Science:
- Neuroscience
- Clinical Electrophysiology
Background:
- Monoamine oxidase inhibitors (MAOIs) like nialamide are known to affect neurotransmitter systems.
- Centrencephalic electroencephalogram (EEG) abnormalities are associated with brainstem monoamine pathways.
- Investigating provocative EEG methods can aid in diagnosing neurological conditions.
Observation:
- Nialamide administration was used to provoke centrencephalic EEG abnormalities (6-14 Hz positive spikes).
- The study included 49 inpatients with existing centrencephalic discharges (epilepsy, anorexia nervosa, narcolepsy, diencephalosis) and 22 controls.
- Nialamide was administered to assess its effect on EEG patterns and clinical symptoms.
Findings:
- Nialamide provoked increased EEG abnormalities in 71.4% (35/49) of patients with pre-existing centrencephalic discharges.
- The drug also exacerbated clinical symptoms in 26 of these 49 patients.
- No EEG abnormalities or symptom provocation were observed in the 22 control patients without centrencephalic discharges.
Implications:
- Nialamide serves as a valuable provocative agent for identifying latent centrencephalic EEG abnormalities.
- This method may help in diagnosing and understanding conditions linked to brainstem monoamine dysfunction.
- The dual effect on EEG and symptoms suggests nialamide's impact on both neural activity and clinical presentation.